Aurobindo And MSN Labs Join Others In Settling On Allergan’s Fetzima
Hikma Has Settlement Agreement And Only Approved ANDA
Two more ANDA companies have reached settlement agreements with AbbVie’s Allergan subsidiary and partner Pierre Fabre Medicament over proposed generic versions of the Fetzima serotonin and norepinephrine reuptake inhibitor.
